bpc 157 nasal spray bpc-157 dosage + TB-500 BPC-157 Nasal Spray (8mg) BPC-157 50 mcg / TB-500

For future clinical applications, we had previously established a solid-phase synthesis process for BPC157, verified its biological activity in different wound models, and completed preclinical safety evaluations

Although there seems to be some promise for the future, at this point, I think theres too much uncertainty and unnecessary risk involved

Peptide Vials (BPC-157 + TB-500, 10 mg blend each) One 10 mg blend vial covers roughly two weeks at the averaged ~700 mcg/day, so plan about one vial every two weeks

Back to All Clinical Documentation Guides 8

Health product complaints can be directed to Health Canada's compliance directorate at 1-800-267-9675